University/Institutions and Commercial Consulting

Since 1989, C-TASC (Clinical Trial and Surveys Corporation) has served research institutions, biotech/pharmaceutical firms, laboratories and private industry as a clinical trials solutions company supporting the best practices management of:

Clinical trials and cohort studies
Case/control studies
Clinical registries
Laboratory studies

Sleep Disorder Study: Baylor College of Medicine, Texas Childrens Hospital

This is an observational study designed to investigate the effects of HAART treatment on the sleep patterns and related neurocognitive and psychosocial function of participants. Using questionnaires and actigraphy measurements, overnight sleep studies will assess sleeping patterns and daytime sleepiness. Peripheral blood levels will be measured over a 24-hour period at multiple time points.

Johns Hopkins Bloomberg School of Public Health EVI Vaccine Study

This is a Phase 1, open-label, dose de-escalation study designed to refine the existing ETEC H10407 human challenge model. The study is being carried out at the Johns Hopkins Bloomberg School of Public Health. Subjects will be recruited over a 60-day screening window, to be followed by the ETEC H10407 challenge, 28 days of safety and immunology follow-up, and a three month follow-up phone call. Subjects will be inpatient for about 8-9 days.

New York University (NYU) Lung Cancer Biomarker Center—Early Detection Research Network (EDRN)

The study goal is to recruit a large cohort of individuals at high risk for smoking-related cancers, and facilitate the clinical validation and application of biomarkers through their own investigations and through participation in multi-institutional EDRN studies. Since 2001 1,200 individuals have been enrolled and an additional 1,450 individuals will be enrolled and followed prospectively. This study received approval for continuation from the NYU Medical School IRB on November 14, 2008.

Atlantic C-PORT Elective Angioplasty Study with The Johns Hopkins University (JHU) School of Medicine

The Atlantic C-PORT (Cardiovascular Patient Outcomes Research Team) Elective Angioplasty Study investigates the safety and efficacy of performing angioplasty in hospitals without cardiac surgery teams compared to hospitals with cardiac surgery available in the case of an emergency that develops during the angioplasty. This study is conducted in several states, including Maryland